Maternal physiology, antenatal assessment and fetal complications
Define the maternal and fetal questions
Antenatal assessment separates maternal disease, placental function and fetal condition while recognizing their interaction. Establish gestational dating, prior pregnancy outcomes, medications, relevant conditions and the actual symptoms. New hypertension, neurological symptoms, abdominal pain, bleeding or breathlessness require evaluation in context. Proteinuria is one component of preeclampsia assessment, not an indispensable feature of every severe presentation. Platelets, renal and liver findings, pulmonary status and neurological manifestations can change the concern. A HELLP label requires attention to hemolysis as well as liver abnormalities and thrombocytopenia; two abnormal results alone should not silently supply the third.
Screening does not establish every diagnosis
Ultrasound, cell-free DNA screening and invasive diagnostic testing answer different questions. A high-performing aneuploidy screen is still a screen; a negative result cannot exclude every genetic or structural disorder. Marked nuchal translucency warrants an appropriately counseled assessment even when a screening result is reassuring. Tests for maternal infection require attention to timing, assay performance and whether the question concerns maternal exposure, recent infection or confirmed fetal involvement. A single antibody result should not be converted into an exact date of transmission without sufficient evidence.
Growth, fluid and shared placentation
A fetus measuring small may be constitutionally small or affected by restricted growth. The growth trajectory, gestational age, fluid, Doppler findings and wider assessment help distinguish risk. Absent or reversed umbilical-artery end-diastolic flow indicates a different level of concern from a small estimated weight alone. Middle-cerebral-artery velocity can support assessment for fetal anemia but does not replace the complete specialist pathway. Chorionicity matters in twins because shared placental connections can produce disorders such as twin-to-twin transfusion. The appearance of a placental junction on an early scan contributes to classification; it is not a substitute for recording the complete scan.
Choose a coherent plan
Diabetes testing must be interpreted using the specified one-step or two-step framework. A screening challenge is not identical to a diagnostic glucose-tolerance test. Maternal stabilization and fetal assessment proceed together when severe disease develops. The timing of delivery balances actual maternal and fetal risks, gestational age, response and available expertise. A stable preterm patient should not inherit a term-delivery instruction from a superficially similar case. Conversely, an arbitrary gestational-age target must not delay necessary care for deterioration. This section teaches specialist written foundations; it does not establish a local national protocol or reproduce an assessed clinical encounter.